U.S., Aug. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07784452) titled 'Comparing Hepatitis B Vaccination Schedules in Patients on Hemodialysis' on Aug. 20.
Brief Summary: People with kidney failure who are on dialysis have a weaker immune response to the hepatitis B vaccine than healthy people. Even after vaccination, many dialysis patients do not develop enough protection against hepatitis B infection. Doctors do not agree on whether giving 3 doses or 4 doses of the vaccine works better for these patients.
This study will compare two vaccination schedules using a stronger (double) dose of the hepatitis B vaccine in people on maintenance hemodialysis:
Group 1 will receive 3 doses of the vaccine, give...